Skip to content
The Policy VaultThe Policy Vault

MavyretCigna

Genotype 2 or 3 recurrent Hepatitis C Virus post-liver transplantation – new start

Initial criteria

  • Approve for the duration specified in the Hepatitis C – Mavyret PA for PSM Policy criteria if the patient has met the Hepatitis C – Mavyret PA for PSM Policy criteria.

Reauthorization criteria

  • Refer to the Hepatitis C – Mavyret PA for PSM Policy criteria.

Approval duration

duration specified in Mavyret PA for PSM Policy